Finerenone as adjunctive therapy for residual proteinuria in lupus nephritis: a case series of 10 patients - Top-Institutions - MDSpire

Finerenone as adjunctive therapy for residual proteinuria in lupus nephritis: a case series of 10 patients

  • By

  • Rui Gao

  • Jianan Wang

  • Qi Liu

  • Ming Li

  • July 3, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Weifang People’s Hospital
    Weifang People’s Hospital

    Weifang, Shandong

    Key Differentiators

    • Nephrology

  • #2

    Karolinska Institute
    Karolinska Institute

    Stockholm, Sweden

    Key Differentiators

    • Nephrology

  • #3

    Mansoura University Hospital
    Mansoura University Hospital

    Mansoura, Egypt

    Key Differentiators

    • Nephrology

Original Source(s)

Finerenone as adjunctive therapy for residual proteinuria in lupus nephritis: a case series of 10 patients

  • by Rui Gao, Jianan Wang, Qi Liu, Ming Li

  • July 3, 2026

Related Content

Renal osteodystrophy with near-complete bilateral sacroiliac ankylosis: a bat-like pelvic configuration on CT

Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study

Immunological coagulation dual axis stratification identifies ultra high-risk phenotypes in systemic sclerosis